Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

iodine I 124 iododeoxyuridine

Known as: I-124 iododeoxyuridine 
A radiopharmaceutical comprised of the thymidine analog, 5-iodo-2-deoxyuridine (idoxuridine), labeled with the positron emitter iodine I 124. After… Expand
National Institutes of Health

Related topics

Related topics

1 relation
iodine I 124

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma
BackgroundI-124 codrituzumab (aka GC33), an antibody directed at Glypican 3, was evaluated in patients with hepatocellular… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2018
2018
ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor Xenografts.
Antibodies labeled with positron-emitting isotopes have been used for tumor detection, predicting which patients may respond to… Expand
Is this relevant?
2009
2009
Unexpected detection of melanoma brain metastasis by PET with iodine-124 betaCIT.
To study the potential impact of iodine-124-beta-carbomethoxy-3beta(4-iodophenyl)tropane (I-124 betaCIT) in Parkinson disease, a… Expand
  • figure 1
Is this relevant?
2009
2009
No detectable hypoxia in malignant salivary gland tumors: preliminary results.
PURPOSE Hypoxia is detected in most solid tumors and is associated with malignant progression and adverse treatment outcomes… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2005
2005
Modeling Multicellular Response to Nonuniform Distributions of Radioactivity: Differences in Cellular Response to Self-Dose and Cross-Dose
Abstract Howell, R. W. and Neti, P. V. S. V. Modeling Multicellular Response to Nonuniform Distributions of Radioactivity… Expand
Is this relevant?
1993
1993
Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancer.
Studies previously performed in our laboratory demonstrated synergistic cytotoxicity and DNA strand break formation in human… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
1990
1990
Drug-induced perturbations in the in vivo distribution of oncological radiotracers--II. 5-[125I]iodo-2'-deoxyuridine influenced by nitrobenzylthioinosine-5'-phosphate (NBMPR-P) and acyclothymidine…
Nitrobenzylthioinosine (NBMPR), a potent inhibitor of facilitated nucleoside transport in vitro and in vivo, and acyclothymidine… Expand
Is this relevant?
1983
1983
A new brain perfusion imaging agent: [I-123]HIPDM:N,N,N'-trimethyl-N'-[2-hydroxy-3-methyl-5-iodobenzyl]-1,3-propanediamine.
Based on the pH-shift mechanism, a new brain imaging agent I-124 HIPDM (N,N,N'-trimethyl-N'-[2-hydroxy-3-methyl-5-[123I… Expand
Is this relevant?
1981
1981
Preferential utilization of bromodeoxyuridine and iododeoxyuridine triphosphates by DNA polymerase γ in vitro
Thymidine triphosphate (TTP) and its halogenated analog bromodeoxyuridine triphosphate (BrdUTP) were compared in vitro as… Expand
Is this relevant?
1976
1976
Uptake of (125I) iododeoxyuridine in cultured rat and human prostate: effects of insulin and testosterone.
DNA synthetic activity was monitored in rat and human prostate using [125I] iododeoxyuridine ([125I]UdR). Fresh prostate tissue… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE